Donepezil Hydrochloride
Donesyn Contains the Active Substance Donepezil Hydrochloride, Which Belongs to a Group of Medications Called Acetylcholinesterase Inhibitors.
Donesyn is Indicated for the Symptomatic Treatment of Mild to Moderate Alzheimer's Disease. Donesyn Can be Used in Adult Patients.
Before Starting Donesyn, Discuss with the Doctor or Pharmacist if Any of the Following Applies to the Patient:
If the Patient Has or Has Ever Had Heart Problems (Especially Sick Sinus Syndrome or Similar Conditions Such as Irregular or Very Slow Heartbeat, Heart Failure, Myocardial Infarction). Donepezil May Slow Down the Heart Rate;
There is a Conduction Disorder in the Heart Called "Prolonged QT Interval" or There Have Been Certain Heart Rhythm Disorders Called Torsades de Pointes or There Have Been Previous Instances of "QT Interval Prolongation".
There is a Low Level of Magnesium or Potassium in the Blood.
If the Patient Has Ever Had Stomach or Duodenal Ulcers or is Taking a Certain Type of Pain Relief Medication (Non-Steroidal Anti-Inflammatory Drugs - NSAIDs). The Doctor Should Monitor the Symptoms;
If the Patient Has Difficulty Urinating. The Doctor Should Monitor the Symptoms;
If the Patient Has Ever Had Seizures. Donepezil May Cause a New Seizure.
The Doctor Should Monitor the Symptoms;
If the Patient Has Asthma or Other Chronic Lung Disease. Symptoms May Worsen;
If the Doctor Has Informed the Patient of Intolerance to Certain Sugars, Such as Lactose.
Donesyn Can be Used in Patients with Kidney or Mild to Moderate Liver Disease. However, the Doctor Should be Informed of Kidney or Liver Disease. Patients with Severe Liver Disease Should Not Take Donesyn.
Donesyn is Not Indicated for Use in Children and Adolescents (Below 18 Years of Age).
Tell the Doctor or Pharmacist About All Medications the Patient is Currently Taking or Has Recently Taken, as Well as Any Medications the Patient Plans to Take.
Inform the Doctor if the Patient is Taking the Following Medications:
Food Does Not Affect the Action of the Medication.
Do Not Consume Alcohol While Taking Donesyn, as Alcohol May Change the Effect of the Medication.
Women Taking Donesyn Should Not Breastfeed.
If the Patient is Pregnant or Breastfeeding, Thinks She May be Pregnant or is Planning to Have a Child, She Should Consult a Doctor or Pharmacist Before Taking this Medication.
Alzheimer's Disease May Impair the Ability to Drive or Operate Machinery, So Do Not Perform These Activities Until the Doctor Has Assessed That it is Safe for the Patient to Do So.
Additionally, Donesyn May Cause Drowsiness, Dizziness, and Muscle Cramps. If Any of These Effects Occur, Do Not Drive or Operate Machinery.
If the Patient Has Been Diagnosed with an Intolerance to Certain Sugars, the Patient Should Consult a Doctor Before Taking the Medication.
The Medication Contains Less Than 1 mmol (23 mg) of Sodium per Tablet, Which Means the Medication is Considered "Sodium-Free".
Always Take this Medication Exactly as the Doctor Has Advised. If You are Not Sure, Ask the Doctor or Pharmacist.
The Patient Should Inform the Doctor or Pharmacist of the Name of Their Caregiver. The Caregiver Will Help the Patient Take the Prescribed Medication.
The Dose of Donesyn May Vary Depending on the Duration of Treatment and the Doctor's Recommendations.
The Recommended Initial Dose is One 5 mg Donepezil Hydrochloride Tablet Taken in the Evening.
After One Month, the Doctor May Increase the Dose to One 10 mg Donesyn Tablet (10 mg Donepezil Hydrochloride) Taken in the Evening.
The Maximum Recommended Daily Dose is 10 mg.
In Cases Where the Dose Cannot be Achieved with this Strength, Other Strengths of this Medication are Available.
In Patients with Impaired Renal Function, No Dose Adjustment is Necessary.
In Patients with Mild and Moderate Liver Impairment, Dose Titration Should be Performed According to Individual Patient Tolerance. In Cases of Severe Liver Impairment, Donesyn Should Not be Taken (See Section 2, Before Taking Donesyn). In Cases of Unexplained Liver Disease, the Doctor May Decide to Completely Discontinue Treatment with Donesyn.
The Donesyn Tablet(s) Should be Taken Orally, with Water, in the Evening, Before Bedtime.
If the Patient Experiences Unusual Dreams, Nightmares, or Difficulty Falling Asleep (See Section 4), the Doctor May Recommend Taking Donesyn in the Morning.
The Doctor Will Inform How Long to Take Donesyn. Regular Contact with the Doctor Should be Maintained to Verify the Treatment and Assess the Symptoms.
Symptoms of Overdose May Include: Severe Nausea, Vomiting, Salivation, Excessive Sweating, Bradycardia (Slow Heart Rate), Hypotension, Respiratory Depression. Muscle Weakness (Collapse) and Involuntary Muscle Contractions (Seizures) May Also Occur, as Well as Increasing Muscle Weakness, Which Can be Life-Threatening.
If a Larger Dose of Donesyn is Taken Than Recommended, the Doctor Should be Informed Immediately or the Patient Should Go to the Nearest Hospital. The Package Leaflet and Medication Packaging Should be Taken Along.
Do Not Take a Double Dose to Make Up for a Missed Dose.
Take the Next Dose at the Usual Time.
If Donesyn Has Been Missed for More Than One Week, Consult the Doctor Before Taking the Medication Again.
Do Not Stop Taking the Medication, Even if the Patient Feels Well, Unless the Doctor Recommends it.
If There are Any Further Questions About the Use of this Medication, Ask the Doctor or Pharmacist.
Like All Medications, Donesyn Can Cause Side Effects, Although Not Everybody Gets Them.
Severe Side Effects:
If Any of the Following Severe Side Effects Occur, Seek Medical Attention Immediately, as Prompt Medical Attention May be Necessary.
Very Common(May Affect More Than 1 in 10 People):
Common(May Affect Up to 1 in 10 People):
Uncommon(May Affect Up to 1 in 100 People):
Rare(May Affect Up to 1 in 1,000 People):
Frequency Not Known(Frequency Cannot be Estimated from the Available Data):
Reporting Side Effects
If Any Side Effects Occur, Including Any Not Mentioned in the Package Leaflet, Tell the Doctor or Pharmacist. Side Effects Can be Reported Directly to the Department of Medicinal Product Monitoring, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Jerozolimskie Avenue 181C, 02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side Effects Can Also be Reported to the Marketing Authorization Holder or Their Representative.
Keep the Medication Out of Sight and Reach of Children.
Do Not Use the Medication After the Expiration Date Stated on the Carton and Blister Pack After: EXP.
The Expiration Date Refers to the Last Day of the Specified Month.
Store in a Temperature Below 30°C.
Medications Should Not be Disposed of via Wastewater or Household Waste. Ask the Pharmacist How to Dispose of Medications That are No Longer Needed. This Will Help Protect the Environment.
The Active Substance is Donepezil Hydrochloride.
Each 10 mg Donesyn Film-Coated Tablet Contains 10.44 mg of Donepezil Hydrochloride Monohydrate, Equivalent to 10 mg of Donepezil Hydrochloride, Which is Equivalent to 9.12 mg of Donepezil.
The Other Ingredients of the Tablet Core are: Lactose Monohydrate, Microcrystalline Cellulose (E460), Sodium Carboxymethylcellulose (Type A), Hydroxypropylcellulose (E463), Magnesium Stearate (E470b).
The Ingredients of the Tablet Coating are: Hypromellose (E464), Lactose Monohydrate, Macrogol 4000, Titanium Dioxide (E171), and Yellow Iron Oxide (E172).
Donesyn 10 mg Film-Coated Tablets are Yellow, Round, and Biconvex Tablets with a Notch and the Engraving D9EI on One Side and the Number 10 on the Other Side.
The Film-Coated Tablets are Available in Blisters of 7, 28, 30, 50, 56, 60, 84, 98, 100, 120 Film-Coated Tablets and in Divisible Blisters for Single Doses of 50 Film-Coated Tablets (Exclusively for Hospital Use).
Not All Pack Sizes May be Marketed.
Marketing Authorization Holder:
Vipharm S.A.
A. and F. Radziwiłłów 9
05-850 Ożarów Mazowiecki
Poland
Synthon BV
Microweg 22
6545 CM, Nijmegen
Netherlands
Synthon Hispania S.L.
Castelló 1, Polígono Las Salinas
08830 San Boi de Llobregat
Spain
Germany
Donesyn 10 mg Filmtabletten
Bulgaria
Donesyn 10 mg Филмирана таблетка
Czech Republic
Donpethon 10 mg, Potahovaná Tableta
Estonia
Donesyn 10 mg
Greece
Donepezil Synthon Hispania 10 mg
Finland
Donesyn 10 mg Tabletti
Hungary
Donesyn 10 mg Filmtabletta
Ireland
Donesyn 10 mg Film-Coated Tablets
Iceland
Donesyn 10 mg Filmuhúðaðar Töflur
Lithuania
Donesyn 10 mg Plėvele Dengtos Tabletės
Latvia
Donesyn 10 mg Apvalkotās Tabletes
Norway
Donesyn 10 mg Tablett
Poland
Donesyn
Portugal
Dosylien 10 mg Comprimidos Revestidos por Película
Romania
Donesyn 10 mg
Slovenia
Donesyn 10 mg Filmsko Obložene Tablete
Slovakia
Donesyn 10 mg
Date of Package Leaflet Approval:01.11.2022
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.